3sbio

OverviewSuggest Edit

3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
TypePublic
Founded1993
HQGeorge Town, KY
Website3sbio.com

Locations

3sbio is headquartered in
George Town, Cayman Islands

Location Map

Latest Updates

Employees (est.) (Dec 2021)5,232(-5%)
Job Openings6
Revenue (FY, 2021)¥6.4 B(+15%)
Share Price (Aug 2022)$4.9(-3%)
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

3sbio Office Locations

3sbio has an office in George Town
George Town, KY (HQ)
SIX 2nd Floor Cricket Square, 171 Elgin Ave
Show all (1)

3sbio Financials and Metrics

3sbio Revenue

Embed Graph
View revenue for all periods
3sbio's revenue was reported to be ¥6.38 b in FY, 2021
CNY

Revenue (FY, 2021)

6.4b

Gross profit (FY, 2021)

5.7b

Gross profit margin (FY, 2021), %

89%

Net income (FY, 2021)

1.6b

EBITDA (FY, 2021)

2.2b

EBIT (FY, 2021)

1.8b

Market capitalization (2-Aug-2022)

12.7b

Closing stock price (2-Aug-2022)

4.9

Cash (31-Dec-2021)

2.9b

EV

12.5b
3sbio's current market capitalization is $12.7 b.
Annual
CNYFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

4.6b5.3b5.6b6.4b

Cost of goods sold

(564.0m)(591.4m)(702.0m)(777.3m)

Gross profit

4.1b4.8b5.0b5.7b

Gross profit Margin, %

89%91%89%89%
Half Year
CNYH1, 2019H1, 2020H1, 2021

Revenue

2.6b2.7b3.1b

Cost of goods sold

(292.6m)(303.6m)(360.3m)

Gross profit

2.4b2.4b2.8b

Gross profit Margin, %

90%91%90%
Annual
CNYFY, 2018FY, 2019FY, 2020FY, 2021

Cash

1.8b2.1b3.1b2.9b

Accounts Receivable

1.3b930.8m860.0m1.3b

Prepaid Expenses

45.1m49.1m112.7m233.3m

Inventories

384.6m528.5m619.5m690.5m
Half Year
CNYH1, 2019H1, 2020H1, 2021

Cash

1.4b3.8b2.9b

Accounts Receivable

1.5b1.1b1.2b

Prepaid Expenses

756.4m504.8m582.7m

Inventories

449.8m569.9m681.5m
Annual
CNYFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

1.5b1.2b979.1m1.9b

Depreciation and Amortization

313.3m320.7m342.1m306.4m

Inventories

(35.7m)(124.9m)(93.1m)(67.1m)

Accounts Payable

(51.8m)37.0m53.2m27.1m
Half Year
CNYH1, 2019H1, 2020H1, 2021

Net Income

406.6m818.6m1.0b

Depreciation and Amortization

164.1m167.0m149.0m

Inventories

(66.1m)(37.3m)(57.1m)

Accounts Payable

57.4m16.4m11.7m
CNYFY, 2018

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

1.6 x
Show all financial metrics

3sbio Revenue Breakdown

Embed Graph

3sbio revenue breakdown by business segment: 100.0% from PHARMACEUTICAL DIVERSIFIED

3sbio revenue breakdown by geographic segment: 97.8% from CHINA (PEOPLES REPUBLIC) and 2.2% from Other

3sbio Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

3sbio Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

3sbio Online and Social Media Presence

Embed Graph

3sbio Frequently Asked Questions

  • When was 3sbio founded?

    3sbio was founded in 1993.

  • How many employees does 3sbio have?

    3sbio has 5,232 employees.

  • What is 3sbio revenue?

    Latest 3sbio annual revenue is ¥6.4 b.

  • What is 3sbio revenue per employee?

    Latest 3sbio revenue per employee is ¥1.2 m.

  • Who are 3sbio competitors?

    Competitors of 3sbio include BioNTech, Gracell and Deciphera Pharmaceuticals.

  • Where is 3sbio headquarters?

    3sbio headquarters is located at SIX 2nd Floor Cricket Square, 171 Elgin Ave, George Town.

  • Where are 3sbio offices?

    3sbio has an office in George Town.

  • How many offices does 3sbio have?

    3sbio has 1 office.